LIPOXEN TECHNOLOGIES LTD has a total of 111 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and macromolecular chemistry and polymers are LIPOXEN TECH LTD, NEOVACS and CT INGENIERIA GENETICA BIOTECH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 27 | |
#2 | EPO (European Patent Office) | 22 | |
#3 | WIPO (World Intellectual Property Organization) | 19 | |
#4 | Japan | 13 | |
#5 | China | 10 | |
#6 | Republic of Korea | 6 | |
#7 | Australia | 3 | |
#8 | Canada | 3 | |
#9 | New Zealand | 3 | |
#10 | United Kingdom | 2 | |
#11 | Singapore | 2 | |
#12 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Macromolecular chemistry and polymers | |
#4 | Foods and drinks | |
#5 | Environmental technology | |
#6 | Organic fine chemistry | |
#7 | Chemical engineering | |
#8 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Polysaccharides | |
#6 | Climate change adaptation technologies | |
#7 | Enzymes | |
#8 | Sugars | |
#9 | Separation | |
#10 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Gregoriadis Gregory | 75 |
#2 | Jain Sanjay | 67 |
#3 | Laing Peter | 46 |
#4 | Papaioannou Ioannis | 21 |
#5 | Thobhani Smita | 13 |
#6 | Bacon Andrew David | 12 |
#7 | Haider Stefan | 10 |
#8 | Nath Srijit | 10 |
#9 | Siekmann Juergen | 10 |
#10 | Turecek Peter | 10 |
Publication | Filing date | Title |
---|---|---|
CN102573920A | Glycopolysialylation of non-blood coagulation proteins | |
SG10201401194VA | Glycopolysialylation of non-blood coagulation proteins | |
EP2184054A1 | Small Interfering RNA Delivery | |
EP2115010A1 | Reduction of endotoxin in polysialic acids | |
CN103169984A | N-terminal derivatisation of proteins with polysaccharides | |
EP1928418A1 | Liposomal vaccine compositions comprising a polysaccharide antigen and a protein adjuvant | |
WO2006016168A2 | Sialic acid derivatives | |
WO2006016161A1 | Fractionation of charged polysaccharide | |
CN101039965A | Sialic acid derivatives | |
GB0424269D0 | Polysialylated compounds | |
EP1654289A1 | Polysialic acid derivatives | |
WO2005016949A2 | Sialic acid derivatives | |
GB0325621D0 | Polysialylated compounds | |
US7384923B2 | Liposomes | |
WO2004004758A1 | Method to enhance an immune response of nucleic acid vaccination | |
US6962972B2 | Derivatization of proteins | |
EP1259225A2 | Process of dehydration/rehydration for making liposomes | |
US7381421B2 | Liposomes | |
CA2386024A1 | Liposome-entrapped dna oral vaccines | |
EP1254657A2 | Liposomes |